Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
HealthLynked Corp. (HLYK)
USD2.91
-0.03 (-1.13%)
US OTC Healthcare Medical - Care Facilities
Address
1265 Creekside Parkway 34108
Naples, FL, US
Naples, FL, US
CEO
Michael Thomas Dent
Website
healthlynked.com
IPO
2017-05-05
CIK 1680139 ISIN US42228P3001
Description
HealthLynked Corporation operates a digital platform in the United States for the management and archiving of patient information, utilizing cloud technology. The company's business activities are organized into four main segments: Health Services, Digital HealthCare, Accountable Care Organization/Managed Service Organization (ACO/MSO), and Medical Distribution. The Health Services division offers specialized medical care, including obstetrics and gynecology, and provides functional medicine services with a focus on neurodegenerative conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. This segment also includes "Bridging the Gap Physical Therapy," a practice dedicated to enhancing patient recovery and managing pain without reliance on medication or surgery. The Digital HealthCare division oversees the HealthLynked Network, an online cloud-based system that enables both patients and doctors to monitor medical records. Patients can also input comprehensive personal health details, covering past surgeries, medications, allergies, and family medical histories. Additionally, this division provides an online functionality for patients to schedule appointments with healthcare providers. The ACO/MSO division manages an Accountable Care Organization and a Management Service Organization. These entities assist physician practices in delivering patient care, particularly through the Medicare Shared Savings Program, and offer professional consulting services to other healthcare providers and ACOs under contractual agreements. The Medical Distribution division functions as an online distributor, supplying discounted medical products directly to individual consumers and medical practices. HealthLynked was founded in 2014 and its corporate headquarters are located in Naples, Florida.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.91
-0.03 (-1.13%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1.8K
Beta
1.73
Float Shares
1.95M
Free Float %
66.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.26% | +0.25% | -43.00% | -53.71% | +32.99% | +42.49% | -5.90% | -72.45% | -97.34% | -94.30% | -94.30% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
2.91
Quality scores
Altman Z-Score
-53.11
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-31.4% Q1'26: -45.3% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+46.8% ★ Q1'26: -51.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-136.7% Q1'26: -52.4% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%-108.3% Q1'26: -165.5% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%-7,568.3% Q1'26: -630.9% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.7% Q1'26: +2.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-2.73× Q1'26: -2.78× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.53M
OE per share TTM
-0.89
Owner's Yield
-42.24%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
15.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ANCORA ADVISORS, LLC | — -7.4K (-100.0%) | — -148.0 (-100.0%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD— | 20 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
—
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-16 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.02 | — | 0 | I | ↗ |
| 2025-04-09 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.02 | — | 0 | I | ↗ |
| 2025-03-27 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.03 | — | 0 | I | ↗ |
| 2025-03-20 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 1,353,356 | 0.04 | 50.8K | 1,353,356 | I | ↗ |
| 2025-03-12 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.03 | — | 0 | I | ↗ |
| 2025-03-04 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.05 | — | 0 | I | ↗ |
| 2025-01-15 | Daniel Jeremy | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-01 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 2,000,000 | 0.05 | 100.0K | 0 | D | ↗ |
| 2024-12-31 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 618,750 | 0.02 | 14.0K | 618,750 | I | ↗ |
| 2024-12-17 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.03 | — | 0 | I | ↗ |
| 2024-12-04 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.03 | — | 0 | I | ↗ |
| 2024-09-19 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 9,259,258 | 0.05 | 450.0K | 9,259,258 | — | ↗ |
| 2024-09-17 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 356,063 | 0.05 | 16.6K | 356,063 | — | ↗ |
| 2024-06-27 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 393,750 | 0.08 | 31.9K | 393,750 | — | ↗ |
| 2024-06-25 | Crupi William | Officer | — | D | Common stock | 0 | 0.00 | — | 40,000 | — | ↗ |
| 2024-06-24 | Rosal David | Officer | P-Purchase | A | Common stock | 28,333 | 0.08 | 2.4K | 62,000 | — | ↗ |
| 2024-06-20 | Rosal David | Officer | P-Purchase | A | Common stock | 33,667 | 0.08 | 2.7K | 33,667 | — | ↗ |
| 2024-06-03 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Note | 0 | 0.05 | — | 0 | — | ↗ |
| 2024-04-18 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.05 | — | 0 | I | ↗ |
| 2024-04-10 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.06 | — | 0 | — | ↗ |
| 2024-03-29 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrant | 6,660,000 | 0.06 | 399.6K | 6,660,000 | — | ↗ |
| 2024-03-27 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | 12% Convertible Notes | 0 | 0.06 | — | 0 | — | ↗ |
| 2024-03-11 | Rosal David | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-21 | Crupi William | Officer | — | D | Employee stock option | 72,464 | 0.07 | 5.0K | 0 | — | ↗ |
| 2023-12-01 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrant | 1,500,000 | 0.06 | 90.0K | 1,500,000 | — | ↗ |
| 2023-09-27 | Monahan Heather | Director | A-Award | A | Common Stock | 408,163 | 0.00 | — | 1,181,697 | — | ↗ |
| 2023-09-27 | Hobaica Paul | Director | A-Award | A | Common Stock | 408,163 | 0.00 | — | 569,107 | — | ↗ |
| 2023-09-27 | Hall Daniel L. | Director | A-Award | A | Common Stock | 408,163 | 0.00 | — | 1,181,697 | — | ↗ |
| 2023-09-27 | GASPARINI ROBERT P | Director | A-Award | A | Common Stock | 408,163 | 0.00 | — | 2,880,191 | — | ↗ |
| 2023-09-13 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 850,000 | 0.06 | 51.0K | 850,000 | — | ↗ |
| 2023-08-17 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 500,000 | 0.15 | 75.0K | 500,000 | — | ↗ |
| 2023-06-02 | O'Leary George | Director / Officer | J-Other | A | Warrants to purchase common stock | 261,194 | 0.07 | 17.5K | 261,194 | — | ↗ |
| 2023-05-12 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 654,450 | 0.08 | 50.0K | 654,450 | — | ↗ |
| 2023-03-13 | Hobaica Paul | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-02-14 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 685,185 | 0.14 | 92.5K | 685,185 | — | ↗ |
| 2023-01-27 | O'Leary George | Officer | A-Award | A | Common stock | 50,000 | 0.00 | — | 929,115 | — | ↗ |
| 2023-01-27 | DENT MICHAEL T | Director / Officer / 10% Owner | A-Award | A | Common stock | 50,000 | 0.00 | — | 3,010,640 | — | ↗ |
| 2023-01-13 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 860,215 | 0.09 | 80.0K | 860,215 | — | ↗ |
| 2023-01-05 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Warrants | 96,154 | 0.10 | 10.0K | 96,154 | — | ↗ |
| 2022-12-13 | DENT MICHAEL T | Officer | J-Other | A | Warrants | 3,142,857 | 0.00 | — | 3,142,857 | — | ↗ |
| 2022-12-08 | Monahan Heather | Director | A-Award | A | Common Stock | 536,193 | 0.00 | — | 773,534 | — | ↗ |
| 2022-12-08 | Hall Daniel L. | Director | A-Award | A | Common Stock | 536,193 | 0.00 | — | 773,534 | — | ↗ |
| 2022-12-08 | GASPARINI ROBERT P | Director | A-Award | A | Common Stock | 536,193 | 0.00 | — | 2,472,028 | — | ↗ |
| 2022-10-20 | O'Leary George | Officer | A-Award | A | Options to purchase common stock | 1,200,000 | 0.00 | — | 3,000,000 | — | ↗ |
| 2021-12-21 | O'Leary George | Director / Officer | A-Award | A | Common stock | 2,000 | 0.00 | — | 479,115 | — | ↗ |
| 2021-12-21 | DENT MICHAEL T | Director / Officer / 10% Owner | A-Award | A | Common stock | 2,000 | 0.00 | — | 2,960,640 | — | ↗ |
| 2021-11-22 | O'Leary George | Director / Officer / 10% Owner | A-Award | A | Options to purchase common stock | 500,000 | 0.27 | 133.8K | 500,000 | — | ↗ |
| 2021-11-22 | Monahan Heather | Director | A-Award | A | Common Stock | 74,766 | 0.00 | — | 237,341 | — | ↗ |
| 2021-11-22 | Mino Robert P. | Director | A-Award | A | Common Stock | 74,766 | 0.00 | — | 638,604 | — | ↗ |
| 2021-11-22 | Hall Daniel L. | Director | A-Award | A | Common Stock | 74,766 | 0.00 | — | 237,341 | — | ↗ |
| 2021-11-22 | GASPARINI ROBERT P | Director | A-Award | A | Common Stock | 74,766 | 0.00 | — | 1,935,835 | — | ↗ |
| 2021-11-12 | Monahan Heather | Director | A-Award | A | Common Stock | 68,942 | 0.00 | — | 231,517 | — | ↗ |
| 2021-11-12 | Mino Robert P. | Director | A-Award | A | Common Stock | 68,942 | 0.00 | — | 632,780 | — | ↗ |
| 2021-11-12 | Hall Daniel L. | Director | A-Award | A | Common Stock | 68,942 | 0.00 | — | 231,517 | — | ↗ |
| 2021-11-12 | GASPARINI ROBERT P | Director | A-Award | A | Common Stock | 68,942 | 0.00 | — | 1,930,011 | — | ↗ |
| 2021-07-21 | GASPARINI ROBERT P | Director | X-InTheMoney | A | Common Stock | 312,250 | 0.10 | 31.2K | 1,779,532 | — | ↗ |
| 2021-04-30 | Monahan Heather | Director | A-Award | A | Common Stock | 81,288 | 0.00 | — | 81,288 | — | ↗ |
| 2021-04-30 | Mino Robert P. | Director | A-Award | A | Common Stock | 289,694 | 0.00 | — | 482,551 | — | ↗ |
| 2021-04-30 | GASPARINI ROBERT P | Director | A-Award | A | Common Stock | 354,234 | 0.00 | — | 1,467,282 | — | ↗ |
| 2021-03-02 | Mino Robert P. | Director | P-Purchase | A | Common Stock | 50,000 | 0.50 | 25.0K | 192,857 | — | ↗ |
| 2021-03-01 | O'Leary George | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.50 | 25.0K | 3,757,328 | — | ↗ |
| 2021-01-13 | O'Leary George | Director / Officer | A-Award | A | Common Stock | 5,000 | 0.00 | — | 3,535,213 | — | ↗ |
| 2021-01-13 | DENT MICHAEL T | Director / Officer / 10% Owner | A-Award | A | Common stock | 5,000 | 0.00 | — | 84,955,112 | — | ↗ |
| 2020-11-09 | Hall Daniel L. | Director | A-Award | A | Common Stock | 162,575 | 0.00 | — | 162,575 | — | ↗ |
| 2020-10-27 | Monahan Heather | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-10-19 | O'Leary George | Officer | J-Other | A | Common Stock | 1,130,213 | 0.14 | 160.5K | 3,530,213 | — | ↗ |
| 2020-10-19 | GASPARINI ROBERT P | Director | J-Other | A | Common Stock | 99,437 | 0.14 | 14.1K | 1,113,048 | — | ↗ |
| 2020-10-19 | DENT MICHAEL T | Director / Officer / 10% Owner | J-Other | A | Common stock | 10,573,745 | 0.14 | 1.50M | 84,950,112 | — | ↗ |
| 2020-08-24 | DENT MICHAEL T | Director / Officer | J-Other | A | Common stock | 24,522,727 | 0.12 | 2.94M | 74,376,367 | — | ↗ |
| 2020-07-20 | O'Leary George | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 2,400,000 | — | ↗ |
| 2020-01-03 | Mino Robert P. | Director | A-Award | A | Common Stock | 142,857 | 0.14 | 20.0K | 142,857 | — | ↗ |
| 2019-12-31 | DENT MICHAEL T | Director / Officer / 10% Owner | A-Award | A | Warrant (right to buy) | 1,157,143 | 0.14 | 162.0K | 1,157,143 | — | ↗ |
| 2019-11-26 | Mino Robert P. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-04-30 | GASPARINI ROBERT P | Director | — | D | Common Stock | 0 | 0.00 | — | 1,013,611 | — | ↗ |
| 2018-07-01 | O'Leary George | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 2,200,000 | — | ↗ |
| 2018-02-12 | DENT MICHAEL T | Director / Officer / 10% Owner | A-Award | A | Warrant | 6,678,462 | 0.07 | 434.1K | 8,768,462 | — | ↗ |
| 2017-10-05 | GASPARINI ROBERT P | Director | — | D | Warrants (right to buy) | 126,666 | 0.30 | 38.0K | 0 | — | ↗ |
| 2017-03-24 | O'Leary George | Director / Officer | — | I | Common stock | 0 | 0.00 | — | 2,100,000 | — | ↗ |
| 2017-03-24 | DENT MICHAEL T | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 2,953,640 | — | ↗ |
| 2016-12-31 | O'Leary George | Director / Officer | — | D | Employee Stock Option (right to buy) | 100,000 | 0.08 | 8.0K | 0 | — | ↗ |
| 2016-07-21 | GASPARINI ROBERT P | Director | — | D | Warrants (right to buy) | 312,500 | 0.10 | 31.3K | 0 | — | ↗ |
| 2016-07-01 | DENT MICHAEL T | Director / Officer / 10% Owner | — | D | Option | 650,000 | 0.08 | 52.0K | 0 | — | ↗ |
| 2015-01-01 | DENT MICHAEL T | Director / Officer / 10% Owner | — | D | Warrant | 2,000,000 | 0.05 | 100.0K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-223.6K
Shares Outstanding
2.94M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Duncan E. McGillivray | Chief Operating Officer | 191.2K | male |
| Jeremy D. Daniel | Chief Financial Officer | 52.3K | male |
| Michael Thomas Dent | Founder, Chairman of the Board & Chief Executive Officer | 35.0K | — |
| Andrew Mavliev | Chief Technology & Product Officer | — | male |
| Mark Cesal | Marketing Manager | — | male |
| Michael George Paisan | Director of Investor Relations & Strategic Partnerships | — | male |
ESG Rating
ESG Score History MEDICAL - CARE FACILITIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HLYK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
